- ENDRA Life Sciences Announces Pricing of $8.0 Million Public Offering
- ENDRA Provides Update Following In-person Meeting with FDA
- ENDRA Life Sciences Reports First Quarter 2024 Financial Results and Provides a Business Update
- ENDRA Life Sciences to Report First Quarter 2024 Financial Results on May 14, 2024
- ENDRA Life Sciences Strengthens Intellectual Property with Issuance of Five New International Patents
- ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
- ENDRA Life Sciences to Report Fourth Quarter 2023 Financial Results on March 28, 2024
More ▼
Key statistics
On Thursday, ENDRA Life Sciences Inc (NDRA:NAQ) closed at 0.1153, 66.62% above the 52 week low of 0.0692 set on Jun 04, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.12 |
---|---|
High | 0.128 |
Low | 0.0951 |
Bid | 0.1091 |
Offer | 0.11 |
Previous close | 0.1389 |
Average volume | 62.18m |
---|---|
Shares outstanding | 11.04m |
Free float | 10.69m |
P/E (TTM) | -- |
Market cap | 2.97m USD |
EPS (TTM) | -1.26 USD |
Data delayed at least 15 minutes, as of Jun 06 2024 21:00 BST.
More ▼